Quantification of neurological blood‐based biomarkers in critically ill patients with COVID‐19: Developing topics

BACKGROUND: Multiple neurological manifestations of COVID‐19 have been reported such as headache, anosmia, ischemic stroke, and cerebral hemorrhages. Objective characterization of the acute neurological damage in critically ill patients with COVID‐19 has not yet been reported. METHOD: We performed a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Alzheimers Dement
Autors principals: Cooper, Jennifer, Stukas, Sophie K, Hoiland, Ryan, Thiara, Sonny, Foster, Denise, Mitra, Anish, Panenka, William J, Sekhon, Mypinder S, Wellington, Cheryl L
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Biomarkers
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7883192/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/alz.047682
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars